Plain definitions for the terms you will see on payer forms, coverage policies and denial letters.
Developed and reviewed by the ADCES Diabetes Technology Committee. Last reviewed October 2026
About these definitions: General definitions for education. Payer terms, criteria and processes vary by plan.
Terms that sound alike but mean different things. Select a term for its full definition.
It depends on the plan. Benefit verification tells you which applies.
Read the policy to find the criteria.
Document prior therapy when required, or provide clinical justification for an exception to step therapy or preferred therapy requirements, as applicable.
They can run at the same time, but a peer-to-peer request does not pause the appeal deadline.
The nonclinical requirements that must be completed for a prior authorization request to be processed, such as use of a specific form or portal, required fields, signatures, supporting documents or submission method. Administrative requirements vary by payer and plan.
A formal request asking a health plan to reconsider a denial of coverage. An effective appeal addresses the specific reason for denial and provides documentation showing how the person meets the payer’s coverage criteria.
The length of time a payer authorizes coverage for a medication, device, service or supply. When the approval period ends, reauthorization or renewal may be required to continue coverage.
Technology that can assist with tasks such as organizing clinical information, identifying documentation gaps and drafting structured language. AI-generated content must be reviewed for accuracy, privacy and compliance, and verified against the medical record and current payer requirements before use.
A system that combines an insulin pump, continuous glucose monitor (CGM) and algorithm to automatically adjust insulin delivery based on glucose data. PA requirements may include documentation related to insulin therapy, CGM use, training and other payer-specific clinical criteria.
The process of confirming a person’s health plan coverage for a specific medication, device, service or supply. Benefit verification can help identify the applicable benefit, whether prior authorization is required and other coverage requirements that may affect access.
The specific clinical requirements a payer uses to determine whether a medication, device, service or supply qualifies for coverage. Criteria may include diagnosis, insulin use, laboratory values, hypoglycemia history, previous therapies, visit frequency or other requirements and vary by payer and plan.
A payer document describing the criteria and documentation requirements used to determine coverage for a particular therapy, service or technology. Reviewing the policy before submitting a prior authorization can help identify exactly what must be documented.
Ongoing payer coverage for a previously approved medication, device, service or supply. Continued coverage may depend on meeting plan-specific requirements, such as follow-up visits or documentation of continued medical necessity. These requirements do not always involve obtaining a new prior authorization.
A payer’s decision not to approve a requested medication, device, service or supply. A denial should identify the reason coverage was not approved and may provide instructions for reconsideration or appeal.
A standardized code used to identify a person’s diagnosis or clinical condition. Diagnosis codes submitted with a prior authorization should accurately reflect the documented clinical picture because payers may use them when applying coverage criteria.
The portion of a health plan’s medical benefit used to cover certain medical equipment and supplies. Some diabetes devices/technologies, including certain CGMs, insulin pumps and related supplies, may be processed through the DME benefit and may need to be obtained from an approved DME supplier rather than the pharmacy benefit.
A shortcut tool built into an electronic health record that lets users insert prewritten blocks of text, templates or patient data. Smart phrases or dot phrases can help care teams consistently capture information commonly needed for prior authorization, such as diagnosis, insulin regimen, glucose monitoring, laboratory results, hypoglycemia history and medical necessity.
A health plan’s list of covered prescription medications and, in some cases, related products. Formularies may designate preferred products and establish requirements such as prior authorization or step therapy. This list is continually updated and coverage varies by health plan.
The first request submitted to a payer for authorization of a medication, device or service. Initial requests generally require clinical documentation demonstrating that the payer’s coverage criteria are met.
A clinical letter explaining why a requested medication, device or service is medically necessary for a particular person. A strong LMN connects the person’s documented clinical history and needs with the requested device and applicable payer coverage criteria.
The portion of health insurance that covers medical services and certain equipment and supplies. Some diabetes technology is covered through the medical or DME benefit rather than the pharmacy benefit.
The clinical rationale demonstrating why a particular medication, device, service or supply is needed for an individual. For prior authorization, documentation should clearly connect the person’s clinical circumstances with the need for the requested device.
A request for coverage of a medication, device, service or supply that does not meet a payer’s standard coverage requirements but is clinically appropriate for an individual’s needs. Supporting documentation explains why the requested therapy is medically necessary and why available covered alternatives may not be appropriate. Exceptions are subject to payer-specific requirements and approval.
Documented clinical information used to support a coverage request or appeal, such as laboratory values, A1C results, glucose reports, documented hypoglycemic events and treatment history.
The organization responsible for administering health coverage and determining whether health care services, medications, devices or supplies meet the plan’s coverage requirements.
Coverage requirements established by an individual payer or health plan. Requirements and documentation can differ across plans, even for the same diabetes technology/device.
A discussion between the treating clinician or prescriber and a payer’s clinical or medical reviewer about a coverage decision. A P2P may be used to clarify the clinical rationale, address a denial or demonstrate how the person meets the payer’s stated criteria.
The portion of health insurance used to cover prescription medications and certain diabetes technologies/devices and supplies dispensed through a pharmacy. CGMs, supplies and some disposable or wearable insulin-delivery devices may be processed through the pharmacy benefit depending on the plan.
A medication, device or other therapy that a payer generally requires or favors for coverage over an alternative product. A person may be required to use a preferred option before another therapy is covered.
A utilization management process that requires a health plan to review a request for a medication, device, service or supply before coverage is authorized. Approval generally depends on documentation demonstrating that the plan’s applicable coverage criteria and requirements have been met.
A medication, treatment, monitoring approach or device used before the requested therapy. Payers may require documentation of previous therapies and their outcomes as part of prior authorization or step therapy requirements.
The process of obtaining continued payer approval after an existing authorization expires. Renewal may require updated clinical information and documentation demonstrating continued eligibility and/or benefit of a previously authorized treatment.
A request asking a payer to review a previous coverage decision, often with clarification or additional clinical documentation. Reconsideration may be part of the formal appeals process or a separate review option, depending on the payer. A reconsideration request does not necessarily extend or replace a formal appeal deadline.
A coverage requirement in which one or more payer-preferred therapies are trialed before the requested therapy will be covered. Documentation of the therapies tried and their outcomes is typically required.
Processes used by health plans to evaluate and manage the use of health care services, medications and technologies/devices. Prior authorization and step therapy are examples of utilization management tools.
A formal written request for reconsideration following a coverage denial. The appeal should address the payer’s stated reason for denial, provide relevant objective clinical evidence and demonstrate how the applicable coverage criteria are met.
DISCLAIMERS:
This site and its services do not constitute the practice of medical advice, diagnosis or treatment. Always talk to your diabetes care and education specialist or health care provider for diagnosis and treatment, including your specific medical needs. If you have or suspect that you have a medical problem or condition, please contact a qualified health care professional immediately. To find a diabetes care and education specialist near you, visit the ADCES finder tool.
ADCES and danatech curate product specifics and periodically review them for accuracy and relevance. As a result, the information may or may not be the most recent. We recommend visiting the manufacturer's website for the latest details if you have any questions.
danatech, powered by ADCES, helps the whole care team choose, start, use and support diabetes technology with confidence.